INEFFICIENT BACTERIOLYSIS OF ESCHERICHIA-COLI BY SERUM FROM HUMAN NEONATES

被引:12
作者
LASSITER, HA [1 ]
TANNER, JE [1 ]
MILLER, RD [1 ]
机构
[1] UNIV LOUISVILLE,SCH MED,DEPT MICROBIOL & IMMUNOL,LOUISVILLE,KY 40292
关键词
D O I
10.1093/infdis/165.2.290
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To assess bacteriolysis in human neonates, Escherichia coli O7w:K1:NM were incubated with sera from eight healthy neonates, serum pooled from the eight neonates, and serum pooled from healthy adults. The adult serum killed E. coli. In contrast, the bacteria were not killed during incubation with sera from the eight neonates, the pooled neonatal serum, or with heat-inactivated adult serum. However, the combination of pooled neonatal serum and heat-inactivated adult serum killed the bacteria. Supplemental IgG-containing antibodies that bound to E. coli did not enhance the bactericidal activity of the neonatal serum. Ten of 12 blood isolates of E. coli from septic neonates but only 8 of 15 isolates from septic adults were serum-sensitive (killed during incubation with adult serum) (P < .05). Therefore, neonatal serum killed E. coli inefficiently and was deficient in non-IgG heat-stable component(s) required for bacterial killing. Compared with adults, neonates were more frequently septic with serum-sensitive strains of E. coli.
引用
收藏
页码:290 / 298
页数:9
相关论文
共 40 条
[1]  
BALLOW M, 1974, CLIN EXP IMMUNOL, V18, P257
[2]  
CHRISTENSEN HN, 1975, BIOL TRANSPORT, P456
[3]   ROLE OF LIPOPOLYSACCHARIDE AND CAPSULE IN THE SERUM RESISTANCE OF BACTEREMIC STRAINS OF ESCHERICHIA-COLI [J].
CROSS, AS ;
KIM, KS ;
WRIGHT, DC ;
SADOFF, JC ;
GEMSKI, P .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) :497-503
[4]   FUNCTION OF CLASSICAL AND ALTERNATE PATHWAYS OF HUMAN COMPLEMENT IN SERUM TREATED WITH ETHYLENE-GLYCOL TETRAACETIC ACID AND MGCL2-ETHYLENE GLYCOL TETRAACETIC ACID [J].
DESPREZ, RM ;
BRYAN, CS ;
HAWIGER, J ;
COLLEY, DG .
INFECTION AND IMMUNITY, 1975, 11 (06) :1235-1243
[5]  
FEARNON DT, 1979, MOL IMMUNOL, P511
[6]  
FIERER J, 1972, J IMMUNOL, V109, P1156
[7]  
GITLIN D, 1963, PEDIATRICS, V33, P197
[8]   A 10-YEAR REVIEW OF NEONATAL SEPSIS AND COMPARISON WITH THE PREVIOUS 50-YEAR EXPERIENCE [J].
GLADSTONE, IM ;
EHRENKRANZ, RA ;
EDBERG, SC ;
BALTIMORE, RS .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (11) :819-825
[9]   SERUM-RESISTANT MUTANTS OF ESCHERICHIA-COLI-O111 CONTAIN INCREASED LIPOPOLYSACCHARIDE, LACK AN O-ANTIGEN-CONTAINING CAPSULE, AND COVER MORE OF THEIR LIPID-A CORE WITH O-ANTIGEN [J].
GOLDMAN, RC ;
JOINER, K ;
LEIVE, L .
JOURNAL OF BACTERIOLOGY, 1984, 159 (03) :877-882
[10]  
HAENEY MR, 1980, CLIN EXP IMMUNOL, V40, P16